Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19)

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19)

详细信息查看全文

作者：Claudia Marchetti^a ; ^{clamarchetti@libero.it" class="auth_mail" title="E-mail the corresponding author} ; Gabriella Ferrandina^b ; Gennaro Cormio^c ; Angela Gambino^d ; Sabrina Cecere^e ; Domenica Lorusso^f ; Ugo De Giorgi^g ; Stefano Bogliolo^h ; Anna Fagottiⁱ ; ^j ; Serafina Mammoliti^k ; Filomena Narducci^l ; Alice Bergamini^m ; Paolo Scolloⁿ ; Nicoletta Biglia^o ; Enrico Breda^p ; Stefano Tamberi^q ; Marco Marinaccio^r ; Roberto Angioli^s ; Laura Salerno^a ; Maria Chiara Eusebi^d ; Vera Loizzi^c ; Giovanni Scambiaⁱ ; Pierluigi Benedetti Panici^a
关键词：Brain metastasis ; Ovarian cancer ; Platinum sensitivity
刊名：Gynecologic Oncology
出版年：2016
出版时间：December 2016
年：2016
卷：143
期：3
页码：532-538
全文大小：548 K

文摘

•: There is no consensus regarding the best management of patients with BM from EOC.
•: BM is a rare manifestation of EOC, typically occurring in platinum sensitive women.
•: Patients receiving multiple treatments for BM achieve a longer OS.
•: BM from EOC is not a unique disease and tailored treatments should be proposed.